During the past decade, Apex Eye- Kenwood conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Apex Eye- Kenwood" are "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Dry Eye" (1 trials). Many other conditions were trialed in "Apex Eye- Kenwood" in a lesser frequency.

Most popular intervention types in "Apex Eye- Kenwood" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "SHP640" (2 trials), "Brimonidine Tartrate" (1 trials), "PVP-I 0.6%" (1 trials) and "Placebos" (1 trials). Other intervention names were less common.

The vast majority of trials in "Apex Eye- Kenwood" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Apex Eye- Kenwood". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Apex Eye- Kenwood, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Apex Eye- Kenwood, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".